SCHEMBL4058814

SCHEMBL4058814

CCCO[SiH](CCCOCC(CO[Si](C)(C)C)O[Si](C)(C)C)OCCC

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.31
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4061735 0.90
SCHEMBL4065067 0.82 USP2 (0.30) USP2
SCHEMBL4064939 0.81
SCHEMBL4067525 0.81
SCHEMBL8609543 0.80 USP2 (0.44) USP2HTT
SCHEMBL31643142 0.80 USP2 (0.44) USP2HTT
SCHEMBL3892470 0.74 PRKD3 (0.44) USP2HTT
SCHEMBL4062219 0.73 LMNA (0.30)
SCHEMBL4063793 0.72
SCHEMBL4058809 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1600450-B1 Silane compound having at least two protected functional groups and method for preparing the same SHINETSU CHEMICAL CO (JP) 2009-10-21 EP claimed
EP-1600450-B1 Silane compound having at least two protected functional groups and method for preparing the same SHINETSU CHEMICAL CO (JP) 2009-10-21 EP disclosed
US-7053233-B2 Silane compound having at least two protected functional groups and method for preparing the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2006-05-30 US disclosed
EP-1600450-A1 Silane compound having at least two protected functional groups and method for preparing the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-11-30 EP disclosed
US-20050234254-A1 Silane compound having at least two protected functional groups and method for preparing the same SHIN-ETSU CHEMICAL CO., LTD. 2005-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050234254-A1 Silane compound having at least two protected functional groups and method for preparing the same SIN3A, MNS1, RCC1 USP2 1940/4885HTT 3690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.